Amber Wilcox
Staff Scientist
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (6)
Breast cancers are heterogeneous and largely classified using immunohistochemistry of estrogen receptor expression. However, research suggests RNA‐based subtyping, including intrinsic (luminal vs. non‐luminal) and TP53‐based subtypes, may offer additional etiologic insight. TP53 mutant tumors, often more aggressive and non‐luminal, are common among women of African descent. We examined possible heterogeneity for RNA‐based luminal/non‐luminal and TP53 subtypes among women of west African ancestry. We analyzed 595 invasive breast cancer cases and 2096 controls in the Ghana Breast Health Study. RNA was extracted from formalin‐fixed paraffin‐embedded tumor samples and profiled via nCounter® Breast Cancer 360™. Tumors were classified as luminal ( N = 278) vs. non‐luminal ( N = 282) and TP53 wildtype‐like ( N = 324) vs. mutant‐like ( N = 271) using the PAM50 assay and a validated RNA signature, respectively. Case–control odds ratios and 95% confidence intervals were estimated using polytomous logistic regression. Etiologic heterogeneity was assessed in case‐only analyses. Higher parity was more protective for luminal than non‐luminal tumors ( p ‐heterogeneity = .05). Older age at menarche and alcohol use ≥6 months were associated with elevated risk of luminal, but not non‐luminal tumors ( p ‐heterogeneity = .01). Similar trends were observed for TP53 wildtype‐like tumors, though not statistically significant. Cross‐classification of PAM50/TP53 showed that higher parity, older age at menarche, and alcohol use ≥6 months were more strongly associated with luminal/TP53 wildtype‐like than other subtypes. RNA‐based breast cancer subtyping suggests TP53 refines breast cancer etiologic heterogeneity in a sub‐Saharan African population. The high prevalence of aggressive, mostly TP53‐mutant tumors in this population underscores the need for further studies to clarify etiologic heterogeneity.
Year:
2026
Background: Immunotherapy is a rapidly evolving treatment option in breast cancer; However, the breast cancer immune microenvironment is understudied in Black and younger ( Methods: We used histologic and RNA-based immunoprofiling methods to characterize the breast cancer immune landscape in 1,952 tumors from the Carolina Breast Cancer Study (CBCS), a population-based study that oversampled Black ( n = 1,030) and young women ( n = 1,039). We evaluated immune response leveraging markers for 10 immune cell populations, compared profiles to those in The Cancer Genome Atlas (TCGA) Project [ n = 1,095 tumors, Black ( n = 183), and young women ( n = 295)], and evaluated in association with clinical and demographic variables, including recurrence. Results: Consensus clustering identified three immune clusters in CBCS (adaptive-enriched, innate-enriched, or immune-quiet) that varied in frequency by race, age, tumor grade and subtype; however, only two clusters were identified in TCGA, which were predominantly comprised of adaptive-enriched and innate-enriched tumors. In CBCS, the strongest adaptive immune response was observed for basal-like, HER2-positive (HER2 + ), triple-negative breast cancer (TNBC), and high-grade tumors. Younger patients had higher proportions of adaptive-enriched tumors, particularly among estrogen receptor (ER)-negative (ER − ) cases. Black patients had higher frequencies of both adaptive-enriched and innate-enriched tumors. Immune clusters were associated with recurrence among ER − tumors, with adaptive-enriched showing the best and innate-enriched showing the poorest 5-year recurrence-free survival. Conclusions: These data suggest that immune microenvironments are intricately related to race, age, tumor subtype, and grade. Impact: Given higher mortality among Black and young women, more defined immune classification using cell-type–specific panels could help explain higher recurrence and ultimately lead to targetable interventions.
Year:
2025
Background: Diesel exhaust is a complex mixture, including polycyclic aromatic hydrocarbons (PAHs) and nitrated PAHs (nitro-PAHs), many of which are potent mutagens and possible bladder carcinogens. To explore the association between diesel exposure and bladder carcinogenesis, we examined the relationship between exposure and somatic mutations and mutational signatures in bladder tumors. Methods: Targeted sequencing was conducted in bladder tumors from the New England Bladder Cancer Study. Using data on 797 cases and 1,418 controls, two-stage polytomous logistic regression was used to evaluate etiologic heterogeneity between bladder cancer subtypes and quantitative, lifetime estimates of respirable elemental carbon (REC), a surrogate for diesel exposure. Poisson regression was used to evaluate associations between REC and mutational signatures. Results: We observed significant heterogeneity in the diesel-bladder cancer risk relationship, with a strong positive association among cases with high-grade, non-muscle invasive TP53-mutated tumors compared to controls (Odds Ratio(OR)Top Tertile vs.Unexposed=4.8, 95% Confidence Interval(CI)=2.2,10.5; p-trend
Year:
2024
Background: Diesel exhaust is a complex mixture, including polycyclic aromatic hydrocarbons (PAH) and nitrated PAHs (nitro-PAH), many of which are potent mutagens and possible bladder carcinogens. To explore the association between diesel exposure and bladder carcinogenesis, we examined the relationship between exposure and somatic mutations and mutational signatures in bladder tumors. Methods: Targeted sequencing was conducted in bladder tumors from the New England Bladder Cancer Study. Using data on 797 cases and 1,418 controls, two-stage polytomous logistic regression was used to evaluate etiologic heterogeneity between bladder cancer subtypes and quantitative, lifetime estimates of respirable elemental carbon (REC), a surrogate for diesel exposure. Poisson regression was used to evaluate associations between REC and mutational signatures. Results: We observed significant heterogeneity in the diesel-bladder cancer risk relationship, with a strong positive association among cases with high-grade, nonmuscle invasive TP53 -mutated tumors compared with controls [OR Top Tertile vs.Unexposed , 4.8; 95% confidence interval (CI), 2.2–10.5; P trend P heterogeneity = 0.002]. In muscle-invasive tumors, we observed a positive association between diesel exposure and the nitro-PAH signatures of 1,6-dintropyrene (RR, 1.93; 95% CI, 1.28–2.92) and 3-nitrobenzoic acid (RR, 1.97; 95% CI, 1.33–2.92). Conclusions: The relationship between diesel exhaust and bladder cancer was heterogeneous based on the presence of TP53 mutations in tumors, further supporting the link between PAH exposure and TP53 mutations in carcinogenesis. Future studies that can identify nitro-PAH signatures in exposed tumors are warranted to add human data supporting the link between diesel and bladder cancer. Impact: This study provides additional insight into the etiology and possible mechanisms related to diesel exhaust-induced bladder cancer.
Year:
2024
Background: Diesel exhaust is a complex mixture, including polycyclic aromatic hydrocarbons (PAH) and nitrated PAHs (nitro-PAH), many of which are potent mutagens and possible bladder carcinogens. To explore the association between diesel exposure and bladder carcinogenesis, we examined the relationship between exposure and somatic mutations and mutational signatures in bladder tumors. Methods: Targeted sequencing was conducted in bladder tumors from the New England Bladder Cancer Study. Using data on 797 cases and 1,418 controls, two-stage polytomous logistic regression was used to evaluate etiologic heterogeneity between bladder cancer subtypes and quantitative, lifetime estimates of respirable elemental carbon (REC), a surrogate for diesel exposure. Poisson regression was used to evaluate associations between REC and mutational signatures. Results: We observed significant heterogeneity in the diesel-bladder cancer risk relationship, with a strong positive association among cases with high-grade, nonmuscle invasive TP53 -mutated tumors compared with controls [OR Top Tertile vs.Unexposed , 4.8; 95% confidence interval (CI), 2.2–10.5; P trend P heterogeneity = 0.002]. In muscle-invasive tumors, we observed a positive association between diesel exposure and the nitro-PAH signatures of 1,6-dintropyrene (RR, 1.93; 95% CI, 1.28–2.92) and 3-nitrobenzoic acid (RR, 1.97; 95% CI, 1.33–2.92). Conclusions: The relationship between diesel exhaust and bladder cancer was heterogeneous based on the presence of TP53 mutations in tumors, further supporting the link between PAH exposure and TP53 mutations in carcinogenesis. Future studies that can identify nitro-PAH signatures in exposed tumors are warranted to add human data supporting the link between diesel and bladder cancer. Impact: This study provides additional insight into the etiology and possible mechanisms related to diesel exhaust-induced bladder cancer.
Year:
2024
Background: Diesel exhaust is a complex mixture, including polycyclic aromatic hydrocarbons (PAH) and nitrated PAHs (nitro-PAH), many of which are potent mutagens and possible bladder carcinogens. To explore the association between diesel exposure and bladder carcinogenesis, we examined the relationship between exposure and somatic mutations and mutational signatures in bladder tumors. Methods: Targeted sequencing was conducted in bladder tumors from the New England Bladder Cancer Study. Using data on 797 cases and 1,418 controls, two-stage polytomous logistic regression was used to evaluate etiologic heterogeneity between bladder cancer subtypes and quantitative, lifetime estimates of respirable elemental carbon (REC), a surrogate for diesel exposure. Poisson regression was used to evaluate associations between REC and mutational signatures. Results: We observed significant heterogeneity in the diesel-bladder cancer risk relationship, with a strong positive association among cases with high-grade, nonmuscle invasive TP53 -mutated tumors compared with controls [OR Top Tertile vs.Unexposed , 4.8; 95% confidence interval (CI), 2.2–10.5; P trend P heterogeneity = 0.002]. In muscle-invasive tumors, we observed a positive association between diesel exposure and the nitro-PAH signatures of 1,6-dintropyrene (RR, 1.93; 95% CI, 1.28–2.92) and 3-nitrobenzoic acid (RR, 1.97; 95% CI, 1.33–2.92). Conclusions: The relationship between diesel exhaust and bladder cancer was heterogeneous based on the presence of TP53 mutations in tumors, further supporting the link between PAH exposure and TP53 mutations in carcinogenesis. Future studies that can identify nitro-PAH signatures in exposed tumors are warranted to add human data supporting the link between diesel and bladder cancer. Impact: This study provides additional insight into the etiology and possible mechanisms related to diesel exhaust-induced bladder cancer.
Year:
2024
Collaborators (11)
Katherine Hoadley
Associate Professor
University of North Carolina at Chapel Hill
Mustapha Abubakar
National Institutes of Health
Michael Dean
Sr. Investigator
National Cancer Institute
Charles Perou
Professor
University of North Carolina
Yara G Abdou
University of North Carolina at Chapel Hill
Benjamin Calhoun
Associate Professor
University of North Carolina
Melissa A. Troester
Professor
University of North Carolina at Chapel Hill
Stephanie Downs-Canner
University of North Carolina at Chapel Hill
Melissa Friesen
Senior Investigator
National Cancer Institute
Ludmila Prokunina-Olsson
Chief and Senior Investigator
National Cancer Institute
Jonine Figueroa
Senior Investigator and NIH Distinguished Scholar
Division of Cancer Epidemiology and Genetics, National Cancer Institute
Make your next move.
Prepare your application
Review drafts before you send them.